165 related articles for article (PubMed ID: 16823827)
1. All-trans retinoic acid induces p62DOK1 and p56DOK2 expression which enhances induced differentiation and G0 arrest of HL-60 leukemia cells.
Lamkin TJ; Chin V; Yen A
Am J Hematol; 2006 Aug; 81(8):603-15. PubMed ID: 16823827
[TBL] [Abstract][Full Text] [Related]
2. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.
Downer EJ; Johnston DG; Lynch MA
Mol Cell Neurosci; 2013 Sep; 56():148-58. PubMed ID: 23659921
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid induces expression of SLP-76: expression with c-FMS enhances ERK activation and retinoic acid-induced differentiation/G0 arrest of HL-60 cells.
Yen A; Varvayanis S; Smith JL; Lamkin TJ
Eur J Cell Biol; 2006 Feb; 85(2):117-32. PubMed ID: 16439309
[TBL] [Abstract][Full Text] [Related]
4. Dok1 and Dok2 Proteins Regulate Cell Cycle in Hematopoietic Stem and Progenitor Cells.
Coppin E; De Grandis M; Pandolfi PP; Arcangeli ML; Aurrand-Lions M; Nunès JA
J Immunol; 2016 May; 196(10):4110-21. PubMed ID: 27183638
[TBL] [Abstract][Full Text] [Related]
5. Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.
Mihrshahi R; Brown MH
J Immunol; 2010 Dec; 185(12):7216-22. PubMed ID: 21078907
[TBL] [Abstract][Full Text] [Related]
6. Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.
He PF; Xu ZJ; Zhou JD; Li XX; Zhang W; Wu DH; Zhang ZH; Lian XY; Yao XY; Deng ZQ; Lin J; Qian J
J Cell Physiol; 2018 Sep; 233(9):6604-6614. PubMed ID: 29150948
[TBL] [Abstract][Full Text] [Related]
7. Magnolol and honokiol enhance HL-60 human leukemia cell differentiation induced by 1,25-dihydroxyvitamin D3 and retinoic acid.
Fong WF; Tse AK; Poon KH; Wang C
Int J Biochem Cell Biol; 2005 Feb; 37(2):427-41. PubMed ID: 15474987
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of adapter proteins Dok2 and Dok1 in platelets, leading to an association of Dok2 with integrin alphaIIbbeta3.
Hughan SC; Watson SP
J Thromb Haemost; 2007 Feb; 5(2):387-94. PubMed ID: 17092301
[TBL] [Abstract][Full Text] [Related]
9. Role of Dok-1 and Dok-2 in leukemia suppression.
Niki M; Di Cristofano A; Zhao M; Honda H; Hirai H; Van Aelst L; Cordon-Cardo C; Pandolfi PP
J Exp Med; 2004 Dec; 200(12):1689-95. PubMed ID: 15611295
[TBL] [Abstract][Full Text] [Related]
10. Roscovitine enhances All-trans retinoic acid (ATRA)-induced leukemia cell differentiation: Novel effects on signaling molecules for a putative Cdk2 inhibitor.
Rashid A; Duan X; Gao F; Yang M; Yen A
Cell Signal; 2020 Jul; 71():109555. PubMed ID: 32032659
[TBL] [Abstract][Full Text] [Related]
11. Frameshift mutation in the Dok1 gene in chronic lymphocytic leukemia.
Lee S; Roy F; Galmarini CM; Accardi R; Michelon J; Viller A; Cros E; Dumontet C; Sylla BS
Oncogene; 2004 Mar; 23(13):2287-97. PubMed ID: 14730347
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest.
Yen A; Roberson MS; Varvayanis S; Lee AT
Cancer Res; 1998 Jul; 58(14):3163-72. PubMed ID: 9679985
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
14. c-Cbl tyrosine kinase-binding domain mutant G306E abolishes the interaction of c-Cbl with CD38 and fails to promote retinoic acid-induced cell differentiation and G0 arrest.
Shen M; Yen A
J Biol Chem; 2009 Sep; 284(38):25664-77. PubMed ID: 19635790
[TBL] [Abstract][Full Text] [Related]
15. c-Cbl interacts with CD38 and promotes retinoic acid-induced differentiation and G0 arrest of human myeloblastic leukemia cells.
Shen M; Yen A
Cancer Res; 2008 Nov; 68(21):8761-9. PubMed ID: 18974118
[TBL] [Abstract][Full Text] [Related]
16. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Gery S; Koeffler HP; Yokoyama A
Int J Cancer; 2009 Oct; 125(7):1710-20. PubMed ID: 19507250
[TBL] [Abstract][Full Text] [Related]
18. Expression of DOK1, 2, and 3 genes in HTLV-1-infected T cells.
Ohsugi T; Wakamiya M; Morikawa S; Fujita M
Acta Virol; 2016 Jun; 60(2):211-3. PubMed ID: 27265473
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of activity of 1alpha, 25-dihydroxyvitamin D3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an alpha-tocopherol ester of all-trans retinoic acid.
Makishima M; Kanatani Y; Yamamoto-Yamaguchi Y; Honma Y
Blood; 1996 Apr; 87(8):3384-94. PubMed ID: 8605356
[TBL] [Abstract][Full Text] [Related]
20. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia.
Yasuda T; Shirakata M; Iwama A; Ishii A; Ebihara Y; Osawa M; Honda K; Shinohara H; Sudo K; Tsuji K; Nakauchi H; Iwakura Y; Hirai H; Oda H; Yamamoto T; Yamanashi Y
J Exp Med; 2004 Dec; 200(12):1681-7. PubMed ID: 15611294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
